Please login to the form below

Not currently logged in
Email:
Password:

Innovative Medicines Initiative

This page shows the latest Innovative Medicines Initiative news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

There is a substantial need for innovative new treatment options for osteoarthritis, as many patients are unable to find relief with currently available medicines and continue to suffer,” said Ken Verburg, ... Europe launches antimicrobial research

Latest news

More from news
Approximately 4 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    She made major scientific contributions to neuroscience R&D within the pharmaceutical industry at GlaxoSmithkline, and also championed the vision for the Stevenage Bioscience Catalyst and theEuropean Innovative Medicines Initiative (IMI).

  • A quest for innovative solutions A quest for innovative solutions

    to more than 300 with the creation of PRISM (Patient Relevant Innovative Solutions Mission) which seeks out the nuggets of therapeutic value and delivery innovation. ... The innovative Medicines Initiative (IMI), with 5.3bn invested in 90 projects, is a

  • The world is our laboratory The world is our laboratory

    In January we announced the start of phase I clinical trials in the UK and US, production of 400, 000 vaccine regimens and formation of Innovative Medicines Initiative-funded consortia to ... That said, there is a rising demand for innovative medicines

  • The Heart of the Matter 7: Reality Dawns The Heart of the Matter 7: Reality Dawns

    Likewise, European pharmacovigilance legislation implemented in 2012 means the European Medicines Agency (EMA) is now requesting post-marketing observational studies as part of its approval processes. ... In tandem, as the limitations of the

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    Patrick Vink. A European base will also help Cubist build relationships with partners in the region, which include members of the Innovative Medicines Initiative (IMI) - a public-private partnership bringing together

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

  • Innovative Medicines Initiative appoints executive director Innovative Medicines Initiative appoints executive director

    Pierre Meulien joins from Genome Canada . Innovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September. ... Commenting on his appointment, Meulien said: “I am delighted to have been selected to lead

  • IMI picks Ipsen's Marc de Garidel to chair governing board IMI picks Ipsen's Marc de Garidel to chair governing board

    The Innovative Medicines Initiative (IMI) has picked Ipsen's Marc de Garidel to take over as chair of its governing board from Roch Doliveux, who retired as CEO of UCB at ... Its second-phase IMI 2 programme aims to develop next generation vaccines,

  • IMI appoints new chair of scientific committee IMI appoints new chair of scientific committee

    Prof Maria Beatriz da Silva Lima has been elected chair of the Scientific Committee of the Innovative Medicines Initiative (IMI).

  • Hans Lennernas joins board of CMO Recipharm Hans Lennernas joins board of CMO Recipharm

    Prof Lennernäs is currently a professor of biopharmaceuticals at Uppsala University in Sweden, where he manages an Innovative Medicines Initiative (IMI) project called OrBiTo, which aims to improve the delivery of ... We are very pleased to welcome a

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics